Aspen Group, Inc. Announces Closing of $7.5 Million Equity Financing
Apr 10, 2017 12:01 pm UTC| Business
NEW YORK, April 10, 2017 -- Aspen Group, Inc. (OTCQB:ASPU), a postsecondary education company, announced today the closing of a $7.5 million common stock private placement to institutional and accredited investors. ...
American Health Council Names Dr. Weining Zhen, M.D. to Physician Board
Apr 10, 2017 12:00 pm UTC| Business
NEW YORK, April 10, 2017 -- Dr. Weining Zhen, Professor and Medical Director at the University of Nebraska Medical Center in Omaha, has been selected to join the Physician Board at the American Health Council. He will...
Global Eagle Entertainment Names Paul Rainey Chief Financial Officer
Apr 10, 2017 12:00 pm UTC| Business
LOS ANGELES, April 10, 2017 -- Global Eagle Entertainment Inc. (NASDAQ:ENT) (“Global Eagle” or “Company”), a leading provider of global satellite-based connectivity and media to rapidly expanding mobility markets, today...
BroadSoft Receives 2017 Unified Communications Product of the Year Award from TMC
Apr 10, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., April 10, 2017 -- BroadSoft, Inc. (NASDAQ:BSFT) a global market leader in cloud business software for unified communication, collaboration and contact center as a service (UCaaS), announced today that...
Egg Donor Moms Come Out of the “Closet”
Apr 10, 2017 12:00 pm UTC| Business
ROCKVILLE, Md., April 10, 2017 -- It takes a village to raise a child… and sometimes even more. Each year thousands of American women and men rely on donor tissue banks to help begin their families. Like an increasing...
Avivagen Reports Positive Proof of Concept in Preventing C. Difficile Infection
Apr 10, 2017 11:43 am UTC| Business
OTTAWA, April 10, 2017 -- Avivagen Inc. (TSXV:VIV)(OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to...
Apr 10, 2017 11:30 am UTC| Business
BEVERLY, Mass., April 10, 2017 -- Cellceutix Corporation (OTCQB:CTIX), Accelerating Phase 2 trial for the Prevention of Severe Oral Mucositis (SOM)Annual Global Market for SOM may be in the hundreds of millions of...